We provide you with 20 years of free, institutional-grade data for CHRS stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CHRS. Explore the full financial landscape of CHRS stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Wahlstrom Mats | Sale | -99,988 | $0.74 | $73,881 | 2025-05-28 |
| McMichael Bryan J | Sale | -1,711 | $1.39 | $2,378 | 2025-01-22 |
| Lanfear Dennis M | Sale | -11,810 | $1.39 | $16,416 | 2025-01-22 |
| Reider Paul | Sale | -4,858 | $1.39 | $6,753 | 2025-01-22 |
| McMichael Bryan J | Sale | -1,711 | $1.57 | $2,686 | 2025-01-10 |
| Lanfear Dennis M | Sale | -11,810 | $1.66 | $19,605 | 2025-01-07 |
| Reider Paul | Sale | -2,277 | $1.66 | $3,780 | 2025-01-07 |
| Reider Paul | Sale | -2,073 | $1.61 | $3,338 | 2024-12-17 |
| Wahlstrom Mats | Derivatives Exercise | 59,988 | 2024-02-05 | ||
| Lanfear Dennis M | Sale | -11,218 | $2.44 | $27,372 | 2024-01-23 |
| McMichael Bryan J | Sale | -1,707 | $2.44 | $4,165 | 2024-01-23 |
| Reider Paul | Sale | -4,854 | $2.44 | $11,844 | 2024-01-23 |
| McMichael Bryan J | Sale | -1,707 | $2.87 | $4,899 | 2024-01-09 |
| Reider Paul | Sale | -2,275 | $2.92 | $6,643 | 2024-01-08 |
| Lanfear Dennis M | Sale | -11,781 | $2.92 | $34,401 | 2024-01-08 |
| Stilwell McDavid | Sale | -18,440 | $3.33 | $61,405 | 2024-01-03 |
| Reider Paul | Sale | -2,049 | $2.37 | $4,856 | 2023-12-15 |
| Lanfear Dennis M | Sale | -223,100 | $2.02 | $449,770 | 2023-11-24 |
| Lanfear Dennis M | Derivatives Exercise | 299,940 | 2023-11-24 | ||
| Reider Paul | Sale | -2,451 | $6.84 | $16,765 | 2023-04-04 |
| Vexler Vladimir | Sale | -16,278 | $6.84 | $111,342 | 2023-04-04 |
| Stilwell McDavid | Sale | -3,457 | $6.84 | $23,646 | 2023-04-04 |
| Lanfear Dennis M | Grant, award...etc | 86,250 | 2023-01-24 | ||
| McMichael Bryan J | Grant, award...etc | 12,500 | 2023-01-24 | ||
| Vexler Vladimir | Grant, award...etc | 40,000 | 2023-01-24 | ||
| Stilwell McDavid | Grant, award...etc | 40,000 | 2023-01-24 | ||
| Vexler Vladimir | Sale | -7,204 | $9.85 | $70,959 | 2023-01-12 |
| McMichael Bryan J | Sale | -1,699 | $9.58 | $16,276 | 2023-01-10 |
| Stilwell McDavid | Sale | -5,437 | $9.87 | $53,663 | 2023-01-06 |
| Vexler Vladimir | Sale | -5,437 | $9.87 | $53,663 | 2023-01-06 |
| Lanfear Dennis M | Sale | -10,905 | $9.87 | $107,632 | 2023-01-06 |
| Stilwell McDavid | Sale | -3,458 | $12.85 | $44,435 | 2022-04-05 |
| Vexler Vladimir | Sale | -3,458 | $12.85 | $44,435 | 2022-04-05 |
| Wahlstrom Mats | Grant, award...etc | 40,000 | $11.64 | 2022-03-01 | |
| Vexler Vladimir | Sale | -7,733 | $14.3 | $110,582 | 2022-01-12 |
| Lanfear Dennis M | Grant, award...etc | 86,250 | 2022-01-06 | ||
| Vexler Vladimir | Grant, award...etc | 40,000 | 2022-01-06 | ||
| Stilwell McDavid | Grant, award...etc | 40,000 | 2022-01-06 | ||
| Stilwell McDavid | Sale | -3,507 | $16.8 | $58,919 | 2021-10-19 |
| HEALY JAMES | Sale | -434,555 | $18.06 | $7,848,063 | 2021-09-29 |
| Anicetti Vincent R | Grant, award...etc | 50,000 | 2021-07-08 | ||
| Stilwell McDavid | Open Market Purchase | 3,700 | $13.42 | 2021-06-10 | |
| Lanfear Dennis M | Sale | -31,054 | $13.56 | $421,229 | 2021-06-08 |
| Lanfear Dennis M | Derivatives Exercise | 331,054 | 2021-06-08 | ||
| Anicetti Vincent R | Grant, award...etc | 20,000 | 2021-04-30 | ||
| Stilwell McDavid | Grant, award...etc | 20,000 | 2021-04-30 | ||
| Vexler Vladimir | Grant, award...etc | 20,000 | 2021-04-30 | ||
| Vexler Vladimir | Sale | -114,240 | $16.25 | $1,856,263 | 2021-03-11 |
| Vexler Vladimir | Derivatives Exercise | 102,480 | 2021-03-11 | ||
| Anicetti Vincent R | Sale | -26,649 | $15.46 | $412,087 | 2021-03-09 |
| Anicetti Vincent R | Derivatives Exercise | 20,312 | 2021-03-09 | ||
| Anicetti Vincent R | Sale | -2,488 | $17.45 | $43,418 | 2021-02-19 |
| Anicetti Vincent R | Derivatives Exercise | 2,488 | 2021-02-19 | ||
| Viret Jean-Frederic | Sale | -7,402 | $21.55 | $159,513 | 2021-02-03 |
| Viret Jean-Frederic | Derivatives Exercise | 7,402 | 2021-02-03 | ||
| Viret Jean-Frederic | Sale | -46,144 | $20.1 | $927,494 | 2021-01-27 |
| Viret Jean-Frederic | Derivatives Exercise | 40,000 | 2021-01-27 | ||
| Anicetti Vincent R | Sale | -2,500 | $17.94 | $44,852 | 2021-01-21 |
| Anicetti Vincent R | Derivatives Exercise | 2,500 | 2021-01-21 | ||
| Vexler Vladimir | Grant, award...etc | 31,250 | 2021-01-13 | ||
| Viret Jean-Frederic | Grant, award...etc | 31,250 | 2021-01-13 | ||
| Anicetti Vincent R | Grant, award...etc | 31,250 | 2021-01-13 | ||
| Anicetti Vincent R | Sale | -4,080 | $18.18 | $74,174 | 2021-01-12 |
| Viret Jean-Frederic | Sale | -4,080 | $18.18 | $74,174 | 2021-01-12 |
| Vexler Vladimir | Sale | -4,080 | $18.18 | $74,174 | 2021-01-12 |
| Anicetti Vincent R | Sale | -2,500 | $17.51 | $43,780 | 2020-12-21 |
| Anicetti Vincent R | Derivatives Exercise | 2,500 | 2020-12-21 | ||
| Vexler Vladimir | Sale | -67,138 | $18.24 | $1,224,577 | 2020-12-11 |
| Vexler Vladimir | Derivatives Exercise | 47,626 | 2020-12-11 | ||
| Anicetti Vincent R | Sale | -8,791 | $18.42 | $161,896 | 2020-12-09 |
| Anicetti Vincent R | Derivatives Exercise | 8,791 | 2020-12-09 | ||
| Anicetti Vincent R | Sale | -98,756 | $18.67 | $1,844,041 | 2020-12-07 |
| Anicetti Vincent R | Derivatives Exercise | 98,756 | 2020-12-07 | ||
| Anicetti Vincent R | Sale | -22,770 | $17.5 | $398,416 | 2020-11-19 |
| Anicetti Vincent R | Derivatives Exercise | 6,783 | 2020-11-19 | ||
| Viret Jean-Frederic | Derivatives Exercise | 1,500 | 2020-11-19 | ||
| Viret Jean-Frederic | Sale | -1,995 | $17.49 | $34,896 | 2020-11-19 |
| Anicetti Vincent R | Sale | -3,217 | $17.89 | $57,556 | 2020-10-21 |
| Anicetti Vincent R | Derivatives Exercise | 3,217 | 2020-10-21 | ||
| Viret Jean-Frederic | Sale | -6,144 | $19 | $116,736 | 2020-10-16 |
| Anicetti Vincent R | Sale | -5,000 | $18.84 | $94,216 | 2020-09-21 |
| Anicetti Vincent R | Derivatives Exercise | 5,000 | 2020-09-21 | ||
| Anicetti Vincent R | Sale | -5,000 | $19.37 | $96,851 | 2020-08-19 |
| Anicetti Vincent R | Derivatives Exercise | 5,000 | 2020-08-19 | ||
| Anicetti Vincent R | Sale | -15,000 | $18.25 | $273,687 | 2020-07-21 |
| Anicetti Vincent R | Derivatives Exercise | 15,000 | 2020-07-21 | ||
| Lanfear Dennis M | Derivatives Exercise | 29,994 | 2020-07-06 | ||
| Szela Mary T | Sale | -54,997 | $17.58 | $966,759 | 2020-06-24 |
| Szela Mary T | Derivatives Exercise | 54,997 | 2020-06-24 | ||
| Anicetti Vincent R | Sale | -2,500 | $17.22 | $43,050 | 2020-06-19 |
| Anicetti Vincent R | Derivatives Exercise | 2,500 | 2020-06-19 | ||
| Wahlstrom Mats | Sale | -200,000 | $17.15 | $3,430,020 | 2020-06-19 |
| Viret Jean-Frederic | Sale | -1,278 | $17.66 | $22,569 | 2020-05-22 |
| Anicetti Vincent R | Derivatives Exercise | 2,500 | 2020-05-20 | ||
| Anicetti Vincent R | Sale | -3,093 | $17.17 | $53,107 | 2020-05-20 |
| Anicetti Vincent R | Sale | -10,150 | $15.57 | $158,036 | 2020-04-21 |
| Anicetti Vincent R | Derivatives Exercise | 5,000 | 2020-04-21 | ||
| Wahlstrom Mats | Sale | -118,066 | $20.09 | $2,372,017 | 2020-03-05 |
| Viret Jean-Frederic | Sale | -3,159 | $22.33 | $70,552 | 2020-02-21 |
| Viret Jean-Frederic | Derivatives Exercise | 3,159 | 2020-02-21 | ||
| Anicetti Vincent R | Sale | -10,000 | $21.64 | $216,400 | 2020-02-20 |
| Anicetti Vincent R | Derivatives Exercise | 5,000 | 2020-02-20 | ||
| Anicetti Vincent R | Sale | -10,000 | $19.57 | $195,685 | 2020-01-22 |
| Anicetti Vincent R | Derivatives Exercise | 5,000 | 2020-01-22 | ||
| Viret Jean-Frederic | Sale | -6,318 | $19.67 | $124,274 | 2020-01-17 |
| Viret Jean-Frederic | Derivatives Exercise | 6,318 | 2020-01-17 | ||
| Lanfear Dennis M | Sale | -21,516 | $17.73 | $381,479 | 2020-01-14 |
| Lanfear Dennis M | Grant, award...etc | 59,763 | 2020-01-14 | ||
| Vexler Vladimir | Sale | -3,477 | $17.73 | $61,647 | 2020-01-14 |
| Vexler Vladimir | Grant, award...etc | 40,150 | 2020-01-14 | ||
| Anicetti Vincent R | Sale | -7,146 | $17.73 | $126,699 | 2020-01-14 |
| Anicetti Vincent R | Grant, award...etc | 50,816 | 2020-01-14 | ||
| Viret Jean-Frederic | Sale | -7,077 | $17.73 | $125,475 | 2020-01-14 |
| Viret Jean-Frederic | Grant, award...etc | 50,615 | 2020-01-14 |
The information provided in this report about CHRS stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Coherus BioSciences, Inc(NASDAQ:CHRS) 
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its product candidate pipeline...
Website: http://www.coherus.com
Founded: 2010
Full Time Employees: 306
Sector: Healthcare
Industry: Biotechnology